. the investi gators used monthly questionnaires to collect information on both use of vitamin D supplements and the amount of formula and breast milk consumed daily.
Perrine and colleagues' article is par ticularly relevant given the abundance of literature supporting the health benefits of maintaining an optimal vitamin D status. aside from its classic role in bone homeo stasis, vitamin D has considerable effects on the immune and cardiovascular systems; a deficiency of this vitamin might, therefore, impair immunity and increase susceptibility to cardiovascular diseases and respiratory infections. of particular interest to pedi atric practitioners are the effects vitamin D has on immunity, including stimulation of defensin production (such as cathelicidin, which assists in the clearance of pathogens), as well as promotion of selftolerance, which potentially reduces the risk of autoimmune disease. 3 in addition, the ability of vitamin D to regulate cell growth and induce cell differentiation suggests that it might have natural anticancer properties. 3 the results of several observational studies in pediatric populations suggest that vitamin D supplementation in early childhood might protect against numerous health problems, including the develop ment of type 1 diabetes mellitus. 4 in other studies, increased wheezing during a baby's early life showed an inverse relationship with low maternal vitamin D intake during pregnancy. 5 an analysis of data from the national Health and nutrition examination survey showed that vitamin D deficiency (25 hydroxyvitamin D level <37.5 nmol/l) was associated with raised systolic blood pressure and HDl cholesterol levels in a cohort of individuals aged 1-21 years. 6 How ever, largescale epidemiologic studies are needed to confirm these relationships.
adequacy of intake can be difficult to establish for any nutrient, as in many clini cal settings the appropriate ingested amount to achieve desired health outcomes across the lifespan has not yet been defined. Concep tually, biomarkers of nutritional adequacy have been used for this purpose. these bio markers can fall into several different cate gories (the examples given are all relevant to vitamin D status): markers of supply (serum 25hydroxyvitamin D concentration), func tion (levels of parathyroid hormone and alkaline phosphatase), intermediate end points (outcomes that might be indirectly related to health benefits, such as improved calcium absorption and improved BmD), and disease risk or outcomes (rickets and susceptibility to infection and auto immune disease). 7 Functional biomarkers, such as levels of alkaline phosphatase and parathyroid hormone, have been studied in adults. the finding that a 25hydroxyvitamin D serum concentration of ≥80 nmol/l results in a plateau in serum parathyroid hormone levels led to the adoption of 80 nmol/l as the optimal serum 25hydroxyvitamin D level in adults. 8 However, these data have yet to be replicated in infants and children. the vitamin D intake that would lead to desir able immunologic outcomes, such as preven tion of autoimmune disease, infections and cancer, has also not yet been welldefined in either adults or children.
the safety of administering any dose of vitamin D supplementation is of particu lar concern when considering appro priate dosing in children, especially infants. vita min D toxicity is associated with hyper calcemia and hypercalciuria, and potentially nephrocalcinosis and hyperphosphatemia. However, both parents and healthcare prac titioners should be reassured that a daily dose of 400 iu vitamin D is safe in infants, as many decades of experience support this recommendation. moreover, although data obtained in children are scarce, the results the work of Perrine et al. illustrates the gap that exists between the latest sci entific knowledge and the acceptance and incorpora tion of such knowledge into daily clinical practice. However, the study has several limitations; for example, Perrine and colleagues only considered the actual implementation of the aaP recommen dation, as reported by parents, as the study's end point. the study did not account for the efficacy of communication and reinforce ment of this recommendation to parents by healthcare providers, and did not examine the reasons why parents might have chosen not to follow the recommen dation (such as difficulty of administra tion, personal beliefs or safety concerns). moreover, the study was conducted when only the 2003 aaP recommen dation was in effect and, therefore, the researchers could not determine whether any difference in behavior had occurred after the new dose recommendation was made public. a complementary study 10 examined two factors that influenced adherence to the 2003 aaP recommendations: pediatri cians' recommendations to parents and parental acceptance of the recommen dation. only 36.4% of pediatricians recom mended vita min D supplementation for breastfed infants. those who did not recom mend supplementation agreed with the statement that "the recommendation is not evidence based". 10 moreover, only 44.6% of the parents to whom vitamin D supplementation was recommended by their pediatrician actually followed the recommendation. according to the investigators, those parents who did not follow their pediatri cian's advice were influenced by their belief that breast milk contained all of the required levels of nutrients, and the fact that giving vitamins to infants was inconvenient. However, the pediatricians' recommen dation (if given) influenced many parents to administer the supplement. the findings of these two studies 1, 10 under score that in this era of evidencebased medicine, both healthcare pro viders and the public expect the results of highquality research to be the basis for guidelines pub lished by official organizations before widely accepting these recommendations into their daily practice. in reality, clinical practice often lags behind the scientific advances that drive any type of health recommendation. the study by Perrine et al. highlights this point. However, while awaiting the results of ongoing longitu dinal studies the clini cal community occasionally has to accept recom mendations based on less rigorous studies that nonetheless show established shortterm and potential longterm benefit. vitamin D recommendations might need to be reinforced by national campaigns geared toward both healthcare providers and the public. Both groups need to be made aware of the safety and potential benefits of vitamin D supplementation and the fact that without supplementation, infants might be at risk of deficiency of this important nutrient and, potentially, associ ated longterm health problems, such as type 1 diabetes mellitus or cancer in later life. we hope that, with the collection of critically needed longitudinal health outcomes data, pediatric recom mendations for supplementation will soon become more widely accepted, and vitamin D will eventually earn its 'day in the sun' . 
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